Public comment period open for DHHS Aged & Disabled Waiver

State Department of Health and Human Services (reported by KETV Omaha) has opened a public comment period on the Aged & Disabled waiver, inviting stakeholder feedback on proposed program changes. The development is primarily administrative, but material amendments to coverage, service design or reimbursement under the waiver could affect Medicaid-exposed providers and state budgets, so investors in healthcare services and managed-care contracts should monitor for substantive revisions.

Analysis

Market structure: An expanded Aged & Disabled Medicaid waiver disproportionately benefits home- and community-based service (HCBS) providers and managed Medicaid plans that can scale care coordination (likely winners: AMED, ADUS, CNC, MOH, UNH). Skilled nursing operators and healthcare REITs with SNF exposure (OHI, VTR exposure via skilled-nursing tenants) are direct losers as occupancy and per-patient spend migrate home; estimate a secular mix-shift of 5–15% of long-term care spend over 1–3 years if implemented broadly. Competitive dynamics favor vertically integrated players with existing state relationships and workforce scale; boutique SNF operators with high fixed costs lose pricing power.

Risk assessment: Immediate (0–60 days) risk centers on waiver text and state budget votes during the public comment window; probability of material changes or delays ~20–40%. Short-term (3–6 months) risks: state appropriations or FMAP adjustments could reduce projected reimbursement uplifts; long-term (1–3 years) operational risk is labor-cost inflation (>5% YoY) eroding margin gains. Hidden dependencies include CMS approval language and provider capacity constraints; catalysts are CMS sign-off, legislative funding (watch for >3% reimbursement delta), or lawsuits that can reverse outcomes.

Trade implications: Direct plays — establish a 2–3% long position in AMED and a 1–2% position in ADUS, financed by a 1–1.5% short in OHI (pair: long AMED, short OHI). Options: buy 3–6 month AMED call spreads (cost-limited, target +10% upside) and buy OHI 3–6 month puts (protection against downside >15%). Sector rotation: overweight managed Medicaid (CNC, MOH) and HCBS contractors, underweight nursing-home REITs and high-exposure SNF operators. Entry: stage buys after final waiver text or if proposed rate increases >3% within next 30–60 days; take profits at 20–30% or re-evaluate after 12 months.

Contrarian angles: Consensus likely underestimates implementation friction — reimbursement wins may be backloaded, so immediate equity moves could be underdone; conversely, market may overprice long-term secular shift if workforce shortages cap capacity. Historical parallels (2014–2018 HCBS expansions) produced 10–25% revenue increases for scalable home-health names over 18–24 months, not immediate jumps. Watch unintended consequences: sustained Medicaid outflows could widen state muni spreads (trigger: Nebraska 10y muni +30bps), creating cross-asset stress that could reverse equity rallies.

Key Decisions for Investors

• Establish a 2–3% long position in Amedisys (AMED) staged over 30–60 days; add up to +1% if final waiver text shows statewide HCBS reimbursement increases >3% or CMS approval occurs within 60 days.
• Initiate a 1–2% long in Addus HomeCare (ADUS) and hedge with a 1–1.5% short in Omega Healthcare Investors (OHI) to express HCBS upside vs SNF downside; target holding period 6–12 months, take profits at +25% or cut losses at -12%.
• Purchase 3–6 month AMED call spreads (debit-defined risk) sized to ~0.5–1% portfolio risk and buy OHI 3–6 month puts as downside protection if OHI falls >15%; roll or unwind after CMS/state budget outcomes within 90 days.
• Reduce long-duration municipal exposure to states with similar waiver expansions if Nebraska 10y muni yield widens >30bps vs Treasury; shift to short-duration munis or cash-equivalents until fiscal impact is quantified (monitor spreads daily for 30–90 days).